(Q44529174)

English

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

scientific article published on 28 July 2003

Statements

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study (English)
Peter M Okin
Sverker Jern
Stevo Julius
Markku S Nieminen
Steven Snapinn
Katherine E Harris
Peter Aurup
Jonathan M Edelman
Bjorn Dahlof
Losartan Intervention for Endpoint reduction in hypertension Study Investigations
28 July 2003
684-690

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit